Somerset Indus Capital Partners closed its third fund at $288 million, overshooting its $250 million goal.
The capital was raised from a diverse mix of global development finance institutions, banks, and family offices.
The firm focuses on scaling mid-market healthcare delivery, medical devices, and pharma companies across India.
The oversubscription highlights sustained global investor interest in fundamental, recession-resistant Indian healthcare assets.
Read the full story on StartupFox